PolyPid (PYPD) Competitors $3.49 0.00 (0.00%) Closing price 07/3/2025 03:39 PM EasternExtended Trading$3.49 0.00 (0.00%) As of 07/3/2025 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PYPD vs. RCEL, INFU, LUCD, LAKE, PTHL, OBIO, ICAD, LUNG, MGRM, and ZJYLShould you be buying PolyPid stock or one of its competitors? The main competitors of PolyPid include Avita Medical (RCEL), InfuSystem (INFU), Lucid Diagnostics (LUCD), Lakeland Industries (LAKE), Pheton (PTHL), Orchestra BioMed (OBIO), icad (ICAD), Pulmonx (LUNG), Monogram Orthopaedics (MGRM), and Jin Medical International (ZJYL). These companies are all part of the "medical equipment" industry. PolyPid vs. Its Competitors Avita Medical InfuSystem Lucid Diagnostics Lakeland Industries Pheton Orchestra BioMed icad Pulmonx Monogram Orthopaedics Jin Medical International PolyPid (NASDAQ:PYPD) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation. Does the media favor PYPD or RCEL? In the previous week, Avita Medical had 2 more articles in the media than PolyPid. MarketBeat recorded 2 mentions for Avita Medical and 0 mentions for PolyPid. PolyPid's average media sentiment score of 0.00 equaled Avita Medical'saverage media sentiment score. Company Overall Sentiment PolyPid Neutral Avita Medical Neutral Which has stronger earnings & valuation, PYPD or RCEL? PolyPid has higher earnings, but lower revenue than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than PolyPid, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPolyPidN/AN/A-$29.02M-$4.30-0.81Avita Medical$64.25M2.27-$61.85M-$2.19-2.52 Do analysts prefer PYPD or RCEL? PolyPid currently has a consensus target price of $11.80, suggesting a potential upside of 238.11%. Avita Medical has a consensus target price of $16.50, suggesting a potential upside of 199.18%. Given PolyPid's stronger consensus rating and higher possible upside, research analysts clearly believe PolyPid is more favorable than Avita Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PolyPid 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17Avita Medical 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Do institutionals and insiders have more ownership in PYPD or RCEL? 26.5% of PolyPid shares are held by institutional investors. Comparatively, 27.7% of Avita Medical shares are held by institutional investors. 24.7% of PolyPid shares are held by company insiders. Comparatively, 2.8% of Avita Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is PYPD or RCEL more profitable? PolyPid has a net margin of 0.00% compared to Avita Medical's net margin of -79.61%. Avita Medical's return on equity of -632.62% beat PolyPid's return on equity.Company Net Margins Return on Equity Return on Assets PolyPidN/A -1,069.37% -151.85% Avita Medical -79.61%-632.62%-71.72% Which has more volatility & risk, PYPD or RCEL? PolyPid has a beta of 1.32, meaning that its stock price is 32% more volatile than the S&P 500. Comparatively, Avita Medical has a beta of 1.52, meaning that its stock price is 52% more volatile than the S&P 500. SummaryPolyPid beats Avita Medical on 8 of the 15 factors compared between the two stocks. Get PolyPid News Delivered to You Automatically Sign up to receive the latest news and ratings for PYPD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PYPD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PYPD vs. The Competition Export to ExcelMetricPolyPidMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$35.56M$2.41B$5.49B$9.02BDividend YieldN/A1.77%5.38%4.09%P/E Ratio-0.818.9827.4720.28Price / SalesN/A669.85408.30121.41Price / CashN/A157.0736.6357.47Price / Book4.654.638.095.67Net Income-$29.02M$31.34M$3.17B$248.96M7 Day Performance-2.24%3.25%2.82%3.30%1 Month Performance17.11%6.80%3.69%5.20%1 Year Performance-12.75%1.89%35.42%21.37% PolyPid Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PYPDPolyPid2.1542 of 5 stars$3.49flat$11.80+238.1%-12.8%$35.56MN/A-0.8180RCELAvita Medical0.9003 of 5 stars$5.29-2.9%$16.50+211.9%-29.2%$144.07M$64.25M-2.42130Gap UpINFUInfuSystem2.1346 of 5 stars$6.24+2.0%$13.00+108.3%N/A$131.14M$137.58M104.02410High Trading VolumeLUCDLucid Diagnostics2.5604 of 5 stars$1.15-1.7%$3.55+208.7%+44.5%$126.58M$4.35M-0.8670Positive NewsLAKELakeland Industries4.8329 of 5 stars$13.61+3.3%$26.00+91.0%-39.2%$125.40M$167.21M-4.522,100High Trading VolumePTHLPhetonN/A$18.39+0.8%N/AN/A$120.06M$450K0.0011High Trading VolumeOBIOOrchestra BioMed2.8153 of 5 stars$2.68-3.6%$14.20+429.9%-61.8%$106.51M$2.64M-1.514High Trading VolumeICADicad0.7237 of 5 stars$3.81-0.5%N/A+208.6%$105.21M$19.61M-20.05140News CoveragePositive NewsLUNGPulmonx2.636 of 5 stars$2.59-0.4%$11.53+345.0%-56.0%$104.67M$83.79M-1.80250Positive NewsMGRMMonogram Orthopaedics2.3872 of 5 stars$2.89-0.3%$5.40+86.9%+39.9%$103.50M$370K-6.4228Positive NewsZJYLJin Medical InternationalN/A$0.65+0.0%N/A-77.1%$101.74M$23.50M0.00245Positive News Related Companies and Tools Related Companies Avita Medical Alternatives InfuSystem Alternatives Lucid Diagnostics Alternatives Lakeland Industries Alternatives Pheton Alternatives Orchestra BioMed Alternatives icad Alternatives Pulmonx Alternatives Monogram Orthopaedics Alternatives Jin Medical International Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PYPD) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PolyPid Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share PolyPid With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PYPD Stock Alerts